Tags : Cadila Pharma

Cadila Pharma Launches NuPTH Biosimilar to Forteo for the Treatment

Shots: Cadila has launched NuPTH an osteoporosis biosimilar of Forteo in India. The NuPTH is used for treatment of osteoporosis and in patients with increased risk of fracture. The biosimilar NuPTH aims to be cost-effective for patients and will be available as easy to use, pre-filled disposable pen NuPTH is the third biosimilar launched by […]Read More